[144] Globalstar, Inc. SEC Filing
Form 144 notice for Globalstar, Inc. (GSAT): A holder intends to sell 53,479 shares of Common stock on or about 09/25/2025 through Muriel Siebert & Co. The filing states the aggregate market value of the shares to be sold is $1,869,086.00 and reports 126,672,742 shares outstanding for the class. The shares were acquired on 09/24/2025 by equity award vesting from the issuer and payment is listed as compensation. The filing indicates no securities of the issuer were sold by the person in the prior three months and includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer.
- Acquisition method disclosed: Shares were acquired by equity award vesting (09/24/2025), providing a clear provenance for the securities.
 - Full disclosure of sale details: Number of shares (53,479), aggregate market value ($1,869,086.00), broker (Muriel Siebert & Co.), and proposed sale date (09/25/2025) are all provided.
 
- Proposed insider sale: The filer intends to sell 53,479 shares, which may be viewed by some investors as insider selling.
 - No contextual governance details: The filing does not state the seller's role or whether a 10b5-1 plan exists or its adoption date.
 
Insights
TL;DR: Routine Form 144 filing disclosing a planned sale of vested equity of 53,479 shares (approx. $1.87M) on 09/25/2025.
The notice documents a proposed sale pursuant to Rule 144 after an equity award vested 09/24/2025, with the transaction to be executed through Muriel Siebert & Co. The filing provides basic required facts: number of shares, aggregate market value, outstanding share count, acquisition date, and nature of payment (compensation). This is a compliance disclosure rather than a financial performance statement; it does not provide operational or earnings information. Investors should treat this as an insider disposition filing that meets Rule 144 reporting requirements.
TL;DR: Disclosure indicates an insider/beneficiary sale following vesting, with the filer certifying absence of undisclosed material adverse information.
The form records that the securities were acquired by vesting from the issuer and will be sold shortly thereafter, and it includes the certification language required by the form regarding material information and, if applicable, trading plans. The filing contains no additional context on the role of the seller, any trading plan adoption date, or other governance details. As provided, it is a routine regulatory notice documenting an intended sale under Rule 144.